Synapse

← JEADV Clinical Practice

Papers in JEADV Clinical Practice

Page 7 · newest first

  1. Emergence of bullous pemphigoid under treatment of mycosis fungoides with mogamulizumabJEADV Clinical Practice · 2025
  2. Mental Health and Well‐Being Support for Individuals Living With Skin Conditions: A Global Landscape Analysis of Patient Needs and Current ResourcesJEADV Clinical Practice · 2025
  3. Association Between A1c and Cutaneous Dermatophytosis: A Case–Control StudyJEADV Clinical Practice · 2024
  4. Skin Diseases in Long‐Distance RunnersJEADV Clinical Practice · 2024
  5. Lack of Evidence for the Efficacy of Antifungal Medications to Treat Atopic Dermatitis: A Systematic ReviewJEADV Clinical Practice · 2024
  6. Rapid clearance of cutaneous lesions with anifrolumab in SLE (systemic lupus erythematosus) and DLE (discoid lupus erythematosus)JEADV Clinical Practice · 2024
  7. The Impact of Regularly Used Treatments on Daily Life of Cutaneous T‐Cell and B‐Cell Lymphoma PatientsJEADV Clinical Practice · 2024
  8. ChatGPT for Pathology Reports in Cutaneous Lymphoma: Accuracy and Readability in Cutaneous LymphomaJEADV Clinical Practice · 2024
  9. Risankizumab in Oncologic Patients With Psoriasis: A Case SeriesJEADV Clinical Practice · 2024
  10. Pre‐Operative Ultrasonography Guide for Hidradenitis SuppurativaJEADV Clinical Practice · 2024
  11. Validity of the Skin and UV Neoplasia Transplant Risk Assessment Calculator (SUNTRAC) tool in a Dutch cohort of transplant recipientsJEADV Clinical Practice · 2024
  12. Severe pemphigus vulgaris and cervical carcinoma treated with anti PD1 antibody pembrolizumab: A therapeutic dilemma?JEADV Clinical Practice · 2024
  13. AI powered detection and assessment of onychomycosis: A spotlight on yellow and deep learningJEADV Clinical Practice · 2024
  14. A rapidly growing breast tumour in a young womanJEADV Clinical Practice · 2024
  15. Efficacy of brodalumab in psoriasis patients with a body weight >100 kg: Real‐world evidence (RWE) from the LIBERO studyJEADV Clinical Practice · 2024
  16. A case of double‐mutant resistant tinea indotineaeJEADV Clinical Practice · 2024
  17. Skin infections caused by Mycobacterium chelonae: Underestimated, especially in immunocompromised patientsJEADV Clinical Practice · 2024
  18. The role of wearable technology in real‐time skin health monitoringJEADV Clinical Practice · 2024
  19. Improved photoprotection in the UVA/visible radiation boundary region is essential to prevent DNA damage, oxidative stress and gene expression changes in human skinJEADV Clinical Practice · 2024
  20. Is eosinophil cationic protein (ECP) a new predictor for assessing disease control in chronic spontaneous urticaria?JEADV Clinical Practice · 2024
  21. Field therapies for actinic keratosis: an Australian cost‐effectiveness analysisJEADV Clinical Practice · 2024
  22. Therapeutic inertia in the management of patients with moderate to severe psoriasis: A systematic review of cross‐sectional studiesJEADV Clinical Practice · 2024
  23. Angioedema following venipuncture in a patient on angiotensin‐converting enzyme inhibitor and dipeptidyl peptidase‐IV inhibitor therapy: A case reportJEADV Clinical Practice · 2024
  24. Herpes zoster admissions: The majority of patients are not immunisedJEADV Clinical Practice · 2024
  25. What lies beneath: A qualitative review of misinformation on vulval lichen sclerosusJEADV Clinical Practice · 2024
  26. A cross‐sectional study on quality of life in adult indolent systemic mastocytosis and its association with cutaneous involvementJEADV Clinical Practice · 2024
  27. Update on the treatment of BRAFmut metastatic melanoma and future perspectivesJEADV Clinical Practice · 2024
  28. Prescribing patterns amongst UK dermatologists for the treatment of alopecia areata, female pattern hair loss, and frontal fibrosing alopeciaJEADV Clinical Practice · 2024
  29. Combining RNA tape stripping with dermoscopic features for melanoma identificationJEADV Clinical Practice · 2024
  30. Presenting JAK inhibitor safety information to dermatology patientsJEADV Clinical Practice · 2024
  31. Guselkumab for the treatment of pyoderma gangrenosumJEADV Clinical Practice · 2024
  32. The impact of alopecia areata on patients' daily lives: A study using social media in FranceJEADV Clinical Practice · 2024
  33. HIV‐negative HHV8‐positive multicentric Castleman's disease coexistent with atypical Kaposi's sarcomaJEADV Clinical Practice · 2024
  34. Successful treatment of pyoderma gangrenosum with guselkumabJEADV Clinical Practice · 2024
  35. Protocol for high‐intensity focused ultrasound (HIFU) treatment of cutaneous neurofibromasJEADV Clinical Practice · 2024
  36. Novel biophysical skin biomarkers discriminate topical anti‐inflammatory treatments based on their potential for local adverse effectsJEADV Clinical Practice · 2024
  37. Knowledge of Jimmy Buffett's Merkel cell carcinoma and the impact on self‐reported expected skin cancer prevention behavioursJEADV Clinical Practice · 2024
  38. Role of interleukins in dermatology: Exploring the immune mechanisms in skin diseasesJEADV Clinical Practice · 2024
  39. The clinical landscape of HPV vaccination in preventing and treating cutaneous squamous cell carcinomaJEADV Clinical Practice · 2024
  40. Treatment switching and associated economic outcomes in patients with plaque psoriasis treated with biologics: A retrospective analysis of German claims data 2016−2021JEADV Clinical Practice · 2024
  41. Refractory pyoderma gangrenosum in Caucasian adolescent with Takayasu arteritis and life‐threatening infectionsJEADV Clinical Practice · 2024
  42. The global epidemiology of vitiligo: A systematic review and meta‐analysis of the incidence and prevalenceJEADV Clinical Practice · 2024
  43. A clinical trial on the efficacy of mesotherapy with dutasteride for frontal fibrosing alopeciaJEADV Clinical Practice · 2024
  44. Assessing the efficacy of narrowband UVB phototherapy using digital patient questionnaires and patient‐reported outcome measures (PROMs): An observational cohort study of patients with psoriasis and eczemaJEADV Clinical Practice · 2024
  45. Trichoscopy of tinea capitis caused by Microsporum audouiniiJEADV Clinical Practice · 2024
  46. Implementation and evaluation of a patient action plan for patients with atopic dermatitisJEADV Clinical Practice · 2024
  47. Skin matrix meets immunomatrix—Implications for genetic and acquired diseasesJEADV Clinical Practice · 2024
  48. No need for a p value. Comments on analytical decisions in “Rosacea fulminas: An anti‐inflammatory‐based therapeutic approach”JEADV Clinical Practice · 2024
  49. A systematic review of isotretinoin and its contraindications in peanut, soybean and cashew nut allergiesJEADV Clinical Practice · 2024
  50. Extensive polymorphic eruption and lymphocytosis in a 56‐year‐old male—A difficult diagnosis!JEADV Clinical Practice · 2024